FDA Inspection
CoreRX Inc.CoreRX Inc. – FDA Inspection, Jun 14, 2019
Record Details
This FDA Inspection record concerns CoreRX Inc., with an inspection on June 14, 2019, issued by the Florida District Office, covering biologics.
View Company Profile
ID · eca31204-eefa-4624-9cb1-e52a10251f01
Inspection Facts
- Inspection number
- 1105141
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of CoreRX Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2026 | Not classified | Florida District Office | Drug Quality Assurance |
| March 20, 2025 | Not classified | Florida District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| August 13, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 6, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2019 | VAI | Florida District Office | Generic Drug Evaluation |
Other documents for CoreRX Inc.
- FDA Inspection 1304588 - 2026-02-26
- FDA Inspection 1264769 - 2025-03-20
- FDA Inspection 1151289 - 2021-08-13
- FDA Inspection 1119912 - 2020-03-06
- FDA Inspection 1094038 - 2019-06-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.